Paper22884395
Allosteric post-translational modification codes.
Nussinov R and 3 others. Trends Biochem Sci, 2012. Cited by 191 papers, by iCite.
Cite this record
ConductScience Library. Allosteric post-translational modification codes. Papers, record 22884395. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22884395
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, U.S. Gov't, Non-P.H.S., Review
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protein Processing, Post-Translational | Major topic |
| Proteins | Major topic |
| Allosteric Regulation | |
| Humans | |
| Models, Molecular |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| HHSN261200800001E | PHS HHS | United States | PubMed | PubMed | |
| Intramural NIH HHS | United States | PubMed | PubMed | ||
| ZIABC010440 | NIH | NIH RePORTER | |||
| ZIABC010441 | NIH | NIH RePORTER |
Cited by115
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 191 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42309591 | A comprehensive in silico investigation into the deleterious nonsynonymous single nucleotide polymorphisms of the human transcription factor EB (TFEB) gene and their predicted association with cancer. | J Genet Eng Biotechnol | 2026 | https://conductscience.org/library/papers/42309591 | PubMed |
| 42115319 | An SE(3)-equivariant and dynamic multi-modal engine advancing from PTM site prediction to network understanding. | Commun Chem | 2026 | https://conductscience.org/library/papers/42115319 | PubMed |
| 41750316 | The Landscape of SERCA2 in Cardiovascular Diseases: Expression Regulation, Therapeutic Applications, and Emerging Roles. | Biomolecules | 2026 | https://conductscience.org/library/papers/41750316 | PubMed |
| 41427738 | Phosphorylation induces altered protonation states and allosterically regulates Rac1-RhoGDI complex. | Protein Sci | 2026 | https://conductscience.org/library/papers/41427738 | PubMed |
| 41387463 | Hyperglycemia exacerbates osteoarthritis by impairing macrophage efferocytosis through modulation of CD11b lactylation. | Nat Commun | 2025 | https://conductscience.org/library/papers/41387463 | PubMed |
| 41383849 | Survival strategies of mycoplasmas: the critical role of post-translational modifications. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/41383849 | PubMed |
| 41267530 | Decoding Allostery: How Interactions Lock S100B Conformations and What K55A Mutation Teaches Us. | J Chem Inf Model | 2025 | https://conductscience.org/library/papers/41267530 | PubMed |
| 41136353 | Global comparative structural analysis of responses to protein phosphorylation. | Nat Commun | 2025 | https://conductscience.org/library/papers/41136353 | PubMed |
| 40962203 | Allostery in Biomolecular Condensates. | J Mol Biol | 2026 | https://conductscience.org/library/papers/40962203 | PubMed |
| 40884937 | How residence time works in allosteric drugs. | Curr Opin Struct Biol | 2025 | https://conductscience.org/library/papers/40884937 | PubMed |
| 40773148 | Prognostic and immunotherapeutic response prediction in hepatocellular carcinoma: role of non-histone acetylation/deacetylation scoring. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40773148 | PubMed |
| 40727661 | Drug resistance and tumor heterogeneity: cells and ensembles. | Biophys Rev | 2025 | https://conductscience.org/library/papers/40727661 | PubMed |
| 40644533 | Proteins with cognition-associated structural changes in a rat model of aging exhibit reduced refolding capacity. | Sci Adv | 2025 | https://conductscience.org/library/papers/40644533 | PubMed |
| 40447754 | PRMT5 K240lac confers ferroptosis resistance via ALKBH5/SLC7A11 axis in colorectal cancer. | Oncogene | 2025 | https://conductscience.org/library/papers/40447754 | PubMed |
| 40349954 | Allosteric Modulation of SERCA Pumps in Health and Disease: Structural Dynamics, Posttranslational Modifications, and Therapeutic Potential. | J Mol Biol | 2025 | https://conductscience.org/library/papers/40349954 | PubMed |
| 40216017 | ERK Allosteric Activation: The Importance of Two Ordered Phosphorylation Events. | J Mol Biol | 2025 | https://conductscience.org/library/papers/40216017 | PubMed |
| 40100226 | Monitoring Functional Posttranslational Modifications Using a Data-Driven Proteome Informatic Pipeline. | Proteomics | 2025 | https://conductscience.org/library/papers/40100226 | PubMed |
| 40033101 | PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancer. | Nat Cell Biol | 2025 | https://conductscience.org/library/papers/40033101 | PubMed |
| 40020221 | Normalized and Directional Interplay Scoring for the Interrogation of Proteoform Data. | J Proteome Res | 2025 | https://conductscience.org/library/papers/40020221 | PubMed |
| 39851300 | Artificial Intelligence Transforming Post-Translational Modification Research. | Bioengineering (Basel) | 2024 | https://conductscience.org/library/papers/39851300 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22884395
GET https://conductscience.org/api/papers/v1/22884395/cited_by?page=2